Education
About Us
Working with TipRanks
Follow Us
Skye Bioscience, Inc. (SKYE)
NASDAQ:SKYE
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -723.35K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -58.16M | $ -30.19M | $ -34.74M | $ -18.31M | $ -7.85M |
| EBITDA | $ -57.44M | $ -25.29M | $ -36.62M | $ -18.70M | $ -7.72M |
| Net Income | $ -55.92M | $ -26.57M | $ -37.64M | $ -19.48M | $ -8.52M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 25.74M | $ 68.42M | $ 1.26M | $ 1.24M | $ 8.98M |
| Total Assets | $ 28.31M | $ 72.76M | $ 11.94M | $ 9.11M | $ 9.86M |
| Total Debt | $ 273.65K | $ 455.59K | $ 4.62M | $ 1.98M | $ 2.14M |
| Net Debt | $ -5.61M | $ -67.96M | $ 3.36M | $ 738.00K | $ -6.85M |
| Total Liabilities | $ 8.29M | $ 4.61M | $ 14.07M | $ 12.12M | $ 3.99M |
| Stockholders' Equity | $ 20.02M | $ 68.15M | $ -2.13M | $ -3.01M | $ 5.86M |
| Cash Flow | |||||
| Free Cash Flow | $ -43.07M | $ -26.84M | $ -13.96M | $ -12.77M | $ -6.57M |
| Operating Cash Flow | $ -43.06M | $ -25.24M | $ -13.95M | $ -12.74M | $ -6.47M |
| Investing Cash Flow | $ -19.50M | $ -245.62K | $ 6.60M | $ 5.21M | $ -90.87K |
| Financing Cash Flow | $ 29.57K | $ 83.56M | $ 16.44M | $ -208.79K | $ 13.08M |